Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Truist Securities Maintains Hold on NextGen Healthcare, Raises Price Target to $23.95

Author: Benzinga Newsdesk | September 08, 2023 08:33am
Truist Securities analyst Jailendra Singh maintains NextGen Healthcare (NASDAQ:NXGN) with a Hold and raises the price target from $18 to $23.95.

Posted In: NXGN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist